12.15
-0.055(-0.45%)
Currency In USD
| Previous Close | 12.2 |
| Open | 12.14 |
| Day High | 12.69 |
| Day Low | 11.84 |
| 52-Week High | 22.9 |
| 52-Week Low | 8.74 |
| Volume | 10,001 |
| Average Volume | 26,926 |
| Market Cap | 24.86M |
| PE | -1.37 |
| EPS | -8.88 |
| Moving Average 50 Days | 13.35 |
| Moving Average 200 Days | 14.76 |
| Change | -0.06 |
If you invested $1000 in Cadrenal Therapeutics, Inc. Common Stock (CVKD) since IPO date, it would be worth $196.52 as of November 08, 2025 at a share price of $12.145. Whereas If you bought $1000 worth of Cadrenal Therapeutics, Inc. Common Stock (CVKD) shares 1 year ago, it would be worth $684.61 as of November 08, 2025 at a share price of $12.145.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Cadrenal Therapeutics to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30, 2025
GlobeNewswire Inc.
Sep 29, 2025 8:30 PM GMT
PONTE VEDRA, Fla., Sept. 29, 2025 (GLOBE NEWSWIRE) -- Cadrenal Therapeutics, Inc. (Nasdaq: CVKD), a biopharmaceutical company developing transformative therapeutics to overcome the gaps in anticoagulation therapy, today announced that it will parti
Cadrenal Therapeutics Enhances Anticoagulation Pipeline Through Acquisition of eXIthera’s Portfolio of Factor XIa Inhibitors
GlobeNewswire Inc.
Sep 15, 2025 12:00 PM GMT
Acquisition significantly enhances the Company’s pipeline by adding novel assets in acute and chronic anticoagulation settingsCompany is strategically poised to deliver differentiated therapeutics across the spectrum of cardiovascular thrombotic risk